学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

鈴木光幸（スズキミツヨシ）

研究テーマ	胆汁酸・脂質エステル体産生に寄与する腸内細菌叢同定と生理学的作用機序の探索
研究業績（論文）	＜過去3年＞ 1. Suzuki M, Minowa K, Nakano S, Isayama H, Shimizu T. Genetic abnormalities in pancreatitis: An update on diagnosis, clinical features, and treatment. Diagnostics 11: 31, 2021, IF: 3.992/CI:3 2. Suzuki M, Minowa K, Isayama H, Shimizu T. Acute Recurrent and Chronic Pancreatitis in Children. Ped Int 63: 137-49, 2021, IF: 1.617/CI:5 3. Suzuki M, Nakano S, Murano Y, Miharada K. Low birth weight contributes high risk of lifestyle-related diseases: Fetal programing during developmental stage. Juntendo Medical Journal 67: 512-8, 2021, IF:0/CI:0 4. Osaka S, Nakano S, Mizuno T, Hiraoka Y, Minowa K, Hirai S, Mizutani A, Sabu Y, Miura Y, Shimizu T, Kusuhara H, Suzuki M, Hayashi H. A randomized trial to examine the impact of food on pharmacokinetics of 4-phenylbutyrate and change in amino acid availability after a single oral administration of sodium 4-phenylbutyrarte in healthy volunteers. Mol Gene Metab 132: 220-6, 2021, IF:4.204/CI:0 5. Ando H, Inomata Y, Iwanaka T, Kuroda T, Nio M, Matsui A, Yoshida M, Akiyama T, Abukawa D, Inui A, Ushijima K, Obatake M, Kasahara M, Kanamori Y, Kitagawa H, Kudo T, Kubota M, Kuroiwa M, Kono M, Koshinaga T, Komura M, Shinkai M, Suzuki T, Taguchi T, Tajiri T, Nakano M, Nosaka S, Hashimoto T, Hamada Y, Maeda K, Masumoto K, Matsufuji H, Mizuta K, Muraji T, Yagi M, Yamataka A, Yoshida H, Ishige T, Ito R, Okada T, Kubota M, Kumagai H, Komori K, Kondou H, Saito T, Sakamoto S, Sasaki T, Sasaki H, Sanada Y, Sugiura T, Suzuki M, Tainaka T, Tanaka H, Tanikawa K, Fujishiro J, Bessho K, Matsuura T, Mizuochi T, Murakami J, Yanagi T, Yokoi A, Takeuchi K, Nakayama T, Fukuzawa M, Yamashiro Y. Clinical practice guidelines for biliary atresia in Japan: A secondary publication of the abbreviated version translated into English. J Hepatobiliary Pancreat Sci 28: 55-61, 2021, IF:3.149/CI:7 6. Nakajima Y, Osaka S, Mizuno T, Nakano S, Hiraoka Y, Miura Y, Suzuki M, Kusuhara H, Hayashi H. Influence of food on pharmacokinetics, efficacy, and safety of 4-phenylbutyrate in patients with urea cycle disorders. Mol Gene Metab Reports 29: 100799, 2021, IF:2.082/CI:0 7. Sakano M, Suzuki M, Nakano S, Noguchi A, Shimizu T. Alpha-1 antitrypsin deficiency recognized by failure to gain weight in infancy. Ped Int 64: e14874, 2022, IF:1.617/CI:2 8. Hosoi K, Minowa K, Suzuki M, Kudo T, Ohtsuka Y, Tomomasa T, Tajiri H, Kunisaki R, Ishige T, Yamada H, Arai K, Yoden A, Ushijima K, Aomatsu T, Nagata S, Uchida K, Takeuchi K, Shimizu T. Characteristics and frequency of pediatric inflammatory bowel disease-associated pancreatitis: Nationwide survey in Japan. JPGN Reports 3: 1(e162), 2022, IF:0/CI:0 9. Kanno M, Suzuki M (equally first author), Tanikawa K, Numakura C, Matsuzawa, S, Hayasayka K. A heterozygous calcyclin binding protein/Siah1-interacting protein (CACYBP/SIP) gene mutation in a dominant family with paucity of interlobular bile duct. J Hum Gene 67: 393-7, 2022, IF:3.767/CI:0 10. Tajiri H, Bessho K, Nakayama Y, Abukawa D, Iizuka Y, Ito Y, Inui A, Etani Y, Kudo T, Suzuki M, Takano T, Tanaka A, Mizuochi T, Yoko Miyoshi Y, Murakami J. Practice guidelines for management of children with hepatitis C virus infection. Ped Int 64: e14962, 2022, IF: 1.617/CI:1 11. Naritaka N, Sakamoto E, Togawa T, Kusano H, Suzuki M. Urine bile acid profile of a Japanese patient with bile acid amidation defect. Ped Int 64: e15074, 2022, IF: 1.617/CI:1 12. Miyata E, Jimbo K, Kyodo R, Suzuki M, Kudo T, Shimizu T. Differentiation of Yersinia enterocolitica enteritis from other bacterial enteritides by ultrasonography: a single-center case-control study. Pediatrics & Naonatology 63: 262-8, 2022, IF:2.586/CI:2 13. Itai T, Wang Z, Nishimura G, Ohashi H, Guo L, Wakano Y, Sugiura T, Hayakawa H, Okada M, Saisu T, Kitta A, Doi H, Kurosawa K, Hotta Y, Hosono K, Sato M, Shimizu K, Takikawa K, Watanabe S, Ikeda N, Suzuki M, Fujita A, Uchiyama Y, Tsuchida N, Miyatake S, Miyake N, Matsumoto N, Ikegawa S. De novo heterozygous variants in KIF5B cause kyphomelic dysplasia. Clinical Genetics 102: 3-11, 2022, IF:4.296/CI:2 14. Hayashi K, Hoshino E, Suzuki M, Sakai K, Obatake M Takahasi O. Early identification of biliary atresia using subspace and the bootstrap methods. Adv Data Anal Classify 17, 163-79, 2022, IF:2.134/CI:0 15. Tajiri H, Suzuki M, Bessho K, Ito Y, Murakami J, Hatori R, Takano T, Brooks S. The role of serum Mac-2 binding protein glycosylation isomer (M2BPGi) in the assessment of fibrosis due to chronic hepatitis C in childhood. Scientific Reports 12: 11205, 2022, IF:4.997/CI:1 16. Kim S, Szuki M, Minowa K, Nittono H, Shimizu T. Efficacy of tibia counter rotator for the treatment of internal tibial torsion in children. Children 9, 970, 2022, IF:2.835/CI:1 17. Suzuki M, Noguchi A, Shimizu T. Response to ‘AAT deficiency: PIMpalermo and PISiiyama, current diagnosis and future risk’. Ped Int 64: e15306, 2022, IF:1.617/CI:0 18. Takei H, Narushima S, Suzuki M, Kakiyama G, Sasaki T, Murai T, Yamashro Y, Nittono H. Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3β-hydroxy bile acids in feces. J Lip Res 63:100275, 2022, IF:6.676/CI:1 19. Kirino S, Suzuki M, Ogawa T, Takasawa K, Adachi E, Gau M, Takahashi K, Ikeno M, Yamada M, Suzuki H, Kosaki K, Moriyama K, Yoshida M, Morio T, Kashimada K. Clinical report: Chronic liver dysfunction in an individual with an AMOTL1 variant. Eur J Med Genet 65: 104623, 2022, IF:2.465/CI:0 20. Hoshino E, Moriwaki K, Morimoto K, Sakai K, Shimohata N, Konomura K, Urayama KY, Suzuki M, Shimozuma K. Cost-effectiveness analysis of universal screening of biliary atresia in Japan. J Pediartics 253: 101-6, 2022, IF:6.314/CI:0 21. Kashiwagi K, Jimbo K, Suzuki M, Arai Y, Kudo T, Shimizu T. Impact of Anti-TNFα Treatment on the humoral response to the BNT162b2 mRNA COVID-19 vaccine in pediatric inflammatory bowel disease patients. Vaccines 10: 1618, 2022, IF:4.961/CI:0 22. Kakiyama G, Minowa K, Rodriguez-Agudo D, Martin R, Takei H, Mitamura K, Ikegawa S, Suzuki M, Nittono N, Fuchs M, Heuman DM, Zhou H, Pandak WM. Coffee modulates insulin responsive HNF-4α-Cyp7b1 signaling pathway and reduces oxysterol driven liver inflammation in a NAFLD mouse model. Am J Physiol Gastrointest Liver Physiol 323: G488-G500, 2022, IF: 4.877/CI:0 23. Endo Y, Jimbo K, Arai N, Ochi T, Suzuki M, Yamataka A, Shimizu T. A pediatric case of inverted Meckel's diverticulum presenting with cyclic vomiting-like symptoms: A case report and literature review. Children 9: 1817, 2022, IF: 2.835/CI:0 24. Muto Y, Suzuki M, Kakiyama G, Sasaki T, Murai T, Takei H, Nittono H. Profiling urine glucuronidated bile acid across the age group. Metabolites 12: 1230, 2022, IF:5.581/CI:0 25. Nagata M, Jimbo K, Arai N, Kashiwagi K, Tokushima K, Suzuki M, Kudo T, Shimizu T. An isolated intestinal juvenile polyp diagnosed by abdominal ultrasonography and resected by double-balloon endoscopy: A case report and literature review. Diagnostics 13: 494, 2023, IF:3.992/CI:0 26. Hirai S, Suzuki M, Sakurai Y, Nakano S, Minowa K, Shimizu T. Co-existence of TRPV6 variants with other pancreatitis-associated genes affects early-onset chronic pancreatitis. J Pediatr Gastroenterol Nutr 76: 483-8, 2023, IF:3.355/CI:0 27. Kubo Y, Miura T, Obinata K, Hisada K, Suzuki M, Inage E, Yanagisawa N, Shoji H, Ogata N, Shibata J, Shibata T, Shimizu T. Relationship between COVID-19 and Use of Chlorine Dioxide Gas-Releasing Agents in Elementary Schools. Global Journal of Medical Research 23(F2): 1–5, 2023, IF:0/CI:0 28. Minowa K, Rodriguez-Agudo D, Suzuki M, Muto Y, Hirai S, Wang Y, Su L, Zhou H, Chen Q, Lsnefsky E, Mitamura K, Ikegawa S, Takei H, Nittono H, Fuchs M, Pandak WM, Kakiyama G. Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: Initiating hepatic toxicity in NAFLD. J Lip Res 64: 100323, 2023, IF: 6.676/CI:0 29. Kimura K, Jimbo K, Arai N, Sato M, Suzuki M, Kudo T, Yano T, Shimizu T. Eosinophilic enteritis requiring differentiation from chronic enteropathy associated with SLCO2A1 gene: A case report. World J Gastroenterol 29: 1757-64, 2023, IF:5.374/CI:0 30. Fukuda S, Suzuki M, Minowa K, Koga H, Yamataka A, Shimizu T. Pediatric pancreatic endocrine tumor presenting as acute pancreatitis: a case report and review of the literature. Children 10: 900, 2023, IF: 2.835/CI:0 31. Jimbo K, HosoiK, Suzuki M, Kyodo R, Maruyama K, Arai N, Sato M, Miyata R, Hoshino E, Kudo T, Shimizu T. Accuracy of Transperineal Ultrasonography and Superb Micro-vascular Imaging for Assessing Rectal Lesions in Pediatric Ulcerative Colitis: A Prospective Study. J Crohn’s Colitis. 2023 (in press), IF:10.020/CI:0 32. Hoshino E, Muto Y, Sakai K, Shimohata M, Urayama KY, Suzuki M. Age at Surgery and Native Liver Survival in Biliary Atresia: A Systematic Review and Meta-Analysis. Eur J Pediatr. 2023 (in press), IF:3.601/CI:0 33. Fukunaga H, Suzuki M, Sato K, Miyazaki S, Yamashina S, Miyashita M, Takahashi K, Shimizu T. Young adult case of Fontan associated liver disease with hepatocellular carcinoma. Juntendo Medical Journal. 2023 (in press), IF:0/CI:0 34. Suzuki M, Hirai S, Sakurai Y, Shimizu T. Does the coexistence of CELA3B variants with other pancreatitis-related genes enhance childhood pancreatitis development? J Pediatr Gastroenterol Nutr. 2023 (in press), IF:3.355/CI:0 35. 時田章史, 鈴木光幸, 宮澤正顯．感染免疫から考えるCOVID-19検査の使い方．外来小児科2022; 25: 24-32 36. 鈴木光幸，時田章史．小児におけるSARS-CoV-2検出検査における抗原定性法とRT-PCR法の使用経験．小児科臨床74: 1309-12, 2021 37. 石川悟，時田章史，鈴木光幸，山岡正慶，石幡理絵，磯崎宏美，中山葉月，川上雄平，沼田遥，木村國夫，田原麻由，河野香，浦島崇．東京都内の小児における新型コロナウイルス家庭内濃厚接触者のSARS-CoV2検査陽性率の検討．小児科臨床74: 1305-7, 2021 38. 鈴木光幸，平井沙依子，清水俊明．小児の急性膵炎の実態（成人例とは異なる特徴は）．肝胆膵 82: 39-44, 2021 39. 鈴木光幸．「質疑応答プロからプロへ」遺伝性膵炎の疫学，診断，治療法など最近の知見について.日本醫事新報55: 5096, 2021 40. 箕輪圭，鈴木光幸, 清水俊明．血液・腫瘍疾患治療中の症状とその対応 14.急性膵炎. 小児科診療85: 857-62, 2022 41. 鈴木光幸．ライソソーム病：疾患概念と在宅酵素補充療法．難病とケア28: 27-30, 2022 42. 齋藤暢知，鈴木光幸，清水俊明．小児急性膵炎の特徴. 消化器・肝臓内科12: 469-75, 2022 43. 中野聡，平井沙依子，鈴木光幸. 特集Ⅰ早期慢性膵炎，慢性膵炎をめぐる諸問題小児慢性膵炎の特徴と遺伝子異常. 消化器・肝臓内科12: 384-91, 2022 44. 岩原可名人, 西﨑直人, 織田敦子, 鈴木光幸, 草野弘宣, 谷川健, 鹿毛政義, 大日方薫, 岡﨑任晴, 清水俊明. 肝内胆管低形成による胆汁うっ滞型肝障害を認めた超低出生体重児の一例. 小児科臨床75: 365-70, 2022 45. 齊藤寛貴，金成彌，鈴木光幸，平井沙依子，長尾梓，山崎崇志，清水俊明．下肢矯正装具による内股歩行の治療中に異なる基礎疾患が判明した2例. 小児科臨床 75: 1-5, 2022

研究テーマ

胆汁酸・脂質エステル体産生に寄与する腸内細菌叢同定と生理学的作用機序の探索

研究業績（論文）

＜過去3年＞
1. Suzuki M, Minowa K, Nakano S, Isayama H, Shimizu T. Genetic abnormalities in pancreatitis: An update on diagnosis, clinical features, and treatment. Diagnostics 11: 31, 2021, IF: 3.992/CI:3
2. Suzuki M, Minowa K, Isayama H, Shimizu T. Acute Recurrent and Chronic Pancreatitis in Children. Ped Int 63: 137-49, 2021, IF: 1.617/CI:5
3. Suzuki M, Nakano S, Murano Y, Miharada K. Low birth weight contributes high risk of lifestyle-related diseases: Fetal programing during developmental stage. Juntendo Medical Journal 67: 512-8, 2021, IF:0/CI:0
4. Osaka S, Nakano S, Mizuno T, Hiraoka Y, Minowa K, Hirai S, Mizutani A, Sabu Y, Miura Y, Shimizu T, Kusuhara H, Suzuki M, Hayashi H. A randomized trial to examine the impact of food on pharmacokinetics of 4-phenylbutyrate and change in amino acid availability after a single oral administration of sodium 4-phenylbutyrarte in healthy volunteers. Mol Gene Metab 132: 220-6, 2021, IF:4.204/CI:0
5. Ando H, Inomata Y, Iwanaka T, Kuroda T, Nio M, Matsui A, Yoshida M, Akiyama T, Abukawa D, Inui A, Ushijima K, Obatake M, Kasahara M, Kanamori Y, Kitagawa H, Kudo T, Kubota M, Kuroiwa M, Kono M, Koshinaga T, Komura M, Shinkai M, Suzuki T, Taguchi T, Tajiri T, Nakano M, Nosaka S, Hashimoto T, Hamada Y, Maeda K, Masumoto K, Matsufuji H, Mizuta K, Muraji T, Yagi M, Yamataka A, Yoshida H, Ishige T, Ito R, Okada T, Kubota M, Kumagai H, Komori K, Kondou H, Saito T, Sakamoto S, Sasaki T, Sasaki H, Sanada Y, Sugiura T, Suzuki M, Tainaka T, Tanaka H, Tanikawa K, Fujishiro J, Bessho K, Matsuura T, Mizuochi T, Murakami J, Yanagi T, Yokoi A, Takeuchi K, Nakayama T, Fukuzawa M, Yamashiro Y. Clinical practice guidelines for biliary atresia in Japan: A secondary publication of the abbreviated version translated into English. J Hepatobiliary Pancreat Sci 28: 55-61, 2021, IF:3.149/CI:7
6. Nakajima Y, Osaka S, Mizuno T, Nakano S, Hiraoka Y, Miura Y, Suzuki M, Kusuhara H, Hayashi H. Influence of food on pharmacokinetics, efficacy, and safety of 4-phenylbutyrate in patients with urea cycle disorders. Mol Gene Metab Reports 29: 100799, 2021, IF:2.082/CI:0
7. Sakano M, Suzuki M, Nakano S, Noguchi A, Shimizu T. Alpha-1 antitrypsin deficiency recognized by failure to gain weight in infancy. Ped Int 64: e14874, 2022, IF:1.617/CI:2
8. Hosoi K, Minowa K, Suzuki M, Kudo T, Ohtsuka Y, Tomomasa T, Tajiri H, Kunisaki R, Ishige T, Yamada H, Arai K, Yoden A, Ushijima K, Aomatsu T, Nagata S, Uchida K, Takeuchi K, Shimizu T. Characteristics and frequency of pediatric inflammatory bowel disease-associated pancreatitis: Nationwide survey in Japan. JPGN Reports 3: 1(e162), 2022, IF:0/CI:0
9. Kanno M, Suzuki M (equally first author), Tanikawa K, Numakura C, Matsuzawa, S, Hayasayka K. A heterozygous calcyclin binding protein/Siah1-interacting protein (CACYBP/SIP) gene mutation in a dominant family with paucity of interlobular bile duct. J Hum Gene 67: 393-7, 2022, IF:3.767/CI:0
10. Tajiri H, Bessho K, Nakayama Y, Abukawa D, Iizuka Y, Ito Y, Inui A, Etani Y, Kudo T, Suzuki M, Takano T, Tanaka A, Mizuochi T, Yoko Miyoshi Y, Murakami J. Practice guidelines for management of children with hepatitis C virus infection. Ped Int 64: e14962, 2022, IF: 1.617/CI:1
11. Naritaka N, Sakamoto E, Togawa T, Kusano H, Suzuki M. Urine bile acid profile of a Japanese patient with bile acid amidation defect. Ped Int 64: e15074, 2022, IF: 1.617/CI:1
12. Miyata E, Jimbo K, Kyodo R, Suzuki M, Kudo T, Shimizu T. Differentiation of Yersinia enterocolitica enteritis from other bacterial enteritides by ultrasonography: a single-center case-control study. Pediatrics & Naonatology 63: 262-8, 2022, IF:2.586/CI:2
13. Itai T, Wang Z, Nishimura G, Ohashi H, Guo L, Wakano Y, Sugiura T, Hayakawa H, Okada M, Saisu T, Kitta A, Doi H, Kurosawa K, Hotta Y, Hosono K, Sato M, Shimizu K, Takikawa K, Watanabe S, Ikeda N, Suzuki M, Fujita A, Uchiyama Y, Tsuchida N, Miyatake S, Miyake N, Matsumoto N, Ikegawa S. De novo heterozygous variants in KIF5B cause kyphomelic dysplasia. Clinical Genetics 102: 3-11, 2022, IF:4.296/CI:2
14. Hayashi K, Hoshino E, Suzuki M, Sakai K, Obatake M Takahasi O. Early identification of biliary atresia using subspace and the bootstrap methods. Adv Data Anal Classify 17, 163-79, 2022, IF:2.134/CI:0
15. Tajiri H, Suzuki M, Bessho K, Ito Y, Murakami J, Hatori R, Takano T, Brooks S. The role of serum Mac-2 binding protein glycosylation isomer (M2BPGi) in the assessment of fibrosis due to chronic hepatitis C in childhood. Scientific Reports 12: 11205, 2022, IF:4.997/CI:1
16. Kim S, Szuki M, Minowa K, Nittono H, Shimizu T. Efficacy of tibia counter rotator for the treatment of internal tibial torsion in children. Children 9, 970, 2022, IF:2.835/CI:1
17. Suzuki M, Noguchi A, Shimizu T. Response to ‘AAT deficiency: PI*Mpalermo and PI*Siiyama, current diagnosis and future risk’. Ped Int 64: e15306, 2022, IF:1.617/CI:0
18. Takei H, Narushima S, Suzuki M, Kakiyama G, Sasaki T, Murai T, Yamashro Y, Nittono H. Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3β-hydroxy bile acids in feces. J Lip Res 63:100275, 2022, IF:6.676/CI:1
19. Kirino S, Suzuki M, Ogawa T, Takasawa K, Adachi E, Gau M, Takahashi K, Ikeno M, Yamada M, Suzuki H, Kosaki K, Moriyama K, Yoshida M, Morio T, Kashimada K. Clinical report: Chronic liver dysfunction in an individual with an AMOTL1 variant. Eur J Med Genet 65: 104623, 2022, IF:2.465/CI:0
20. Hoshino E, Moriwaki K, Morimoto K, Sakai K, Shimohata N, Konomura K, Urayama KY, Suzuki M, Shimozuma K. Cost-effectiveness analysis of universal screening of biliary atresia in Japan. J Pediartics 253: 101-6, 2022, IF:6.314/CI:0
21. Kashiwagi K, Jimbo K, Suzuki M, Arai Y, Kudo T, Shimizu T. Impact of Anti-TNFα Treatment on the humoral response to the BNT162b2 mRNA COVID-19 vaccine in pediatric inflammatory bowel disease patients. Vaccines 10: 1618, 2022, IF:4.961/CI:0
22. Kakiyama G, Minowa K, Rodriguez-Agudo D, Martin R, Takei H, Mitamura K, Ikegawa S, Suzuki M, Nittono N, Fuchs M, Heuman DM, Zhou H, Pandak WM. Coffee modulates insulin responsive HNF-4α-Cyp7b1 signaling pathway and reduces oxysterol driven liver inflammation in a NAFLD mouse model. Am J Physiol Gastrointest Liver Physiol 323: G488-G500, 2022, IF: 4.877/CI:0
23. Endo Y, Jimbo K, Arai N, Ochi T, Suzuki M, Yamataka A, Shimizu T. A pediatric case of inverted Meckel's diverticulum presenting with cyclic vomiting-like symptoms: A case report and literature review. Children 9: 1817, 2022, IF: 2.835/CI:0
24. Muto Y, Suzuki M, Kakiyama G, Sasaki T, Murai T, Takei H, Nittono H. Profiling urine glucuronidated bile acid across the age group. Metabolites 12: 1230, 2022, IF:5.581/CI:0
25. Nagata M, Jimbo K, Arai N, Kashiwagi K, Tokushima K, Suzuki M, Kudo T, Shimizu T. An isolated intestinal juvenile polyp diagnosed by abdominal ultrasonography and resected by double-balloon endoscopy: A case report and literature review. Diagnostics 13: 494, 2023, IF:3.992/CI:0
26. Hirai S, Suzuki M, Sakurai Y, Nakano S, Minowa K, Shimizu T. Co-existence of TRPV6 variants with other pancreatitis-associated genes affects early-onset chronic pancreatitis. J Pediatr Gastroenterol Nutr 76: 483-8, 2023, IF:3.355/CI:0
27. Kubo Y, Miura T, Obinata K, Hisada K, Suzuki M, Inage E, Yanagisawa N, Shoji H, Ogata N, Shibata J, Shibata T, Shimizu T. Relationship between COVID-19 and Use of Chlorine Dioxide Gas-Releasing Agents in Elementary Schools. Global Journal of Medical Research 23(F2): 1–5, 2023, IF:0/CI:0
28. Minowa K, Rodriguez-Agudo D, Suzuki M, Muto Y, Hirai S, Wang Y, Su L, Zhou H, Chen Q, Lsnefsky E, Mitamura K, Ikegawa S, Takei H, Nittono H, Fuchs M, Pandak WM, Kakiyama G. Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: Initiating hepatic toxicity in NAFLD. J Lip Res 64: 100323, 2023, IF: 6.676/CI:0
29. Kimura K, Jimbo K, Arai N, Sato M, Suzuki M, Kudo T, Yano T, Shimizu T. Eosinophilic enteritis requiring differentiation from chronic enteropathy associated with SLCO2A1 gene: A case report. World J Gastroenterol 29: 1757-64, 2023, IF:5.374/CI:0
30. Fukuda S, Suzuki M, Minowa K, Koga H, Yamataka A, Shimizu T. Pediatric pancreatic endocrine tumor presenting as acute pancreatitis: a case report and review of the literature. Children 10: 900, 2023, IF: 2.835/CI:0
31. Jimbo K, HosoiK, Suzuki M, Kyodo R, Maruyama K, Arai N, Sato M, Miyata R, Hoshino E, Kudo T, Shimizu T. Accuracy of Transperineal Ultrasonography and Superb Micro-vascular Imaging for Assessing Rectal Lesions in Pediatric Ulcerative Colitis: A Prospective Study. J Crohn’s Colitis. 2023 (in press), IF:10.020/CI:0
32. Hoshino E, Muto Y, Sakai K, Shimohata M, Urayama KY, Suzuki M. Age at Surgery and Native Liver Survival in Biliary Atresia: A Systematic Review and Meta-Analysis. Eur J Pediatr. 2023 (in press), IF:3.601/CI:0
33. Fukunaga H, Suzuki M, Sato K, Miyazaki S, Yamashina S, Miyashita M, Takahashi K, Shimizu T. Young adult case of Fontan associated liver disease with hepatocellular carcinoma. Juntendo Medical Journal. 2023 (in press), IF:0/CI:0
34. Suzuki M, Hirai S, Sakurai Y, Shimizu T. Does the coexistence of CELA3B variants with other pancreatitis-related genes enhance childhood pancreatitis development? J Pediatr Gastroenterol Nutr. 2023 (in press), IF:3.355/CI:0
35. 時田章史, 鈴木光幸, 宮澤正顯．感染免疫から考えるCOVID-19検査の使い方．外来小児科2022; 25: 24-32
36. 鈴木光幸，時田章史．小児におけるSARS-CoV-2検出検査における抗原定性法とRT-PCR法の使用経験．小児科臨床74: 1309-12, 2021
37. 石川悟，時田章史，鈴木光幸，山岡正慶，石幡理絵，磯崎宏美，中山葉月，川上雄平，沼田遥，木村國夫，田原麻由，河野香，浦島崇．東京都内の小児における新型コロナウイルス家庭内濃厚接触者のSARS-CoV2検査陽性率の検討．小児科臨床74: 1305-7, 2021
38. 鈴木光幸，平井沙依子，清水俊明．小児の急性膵炎の実態（成人例とは異なる特徴は）．肝胆膵 82: 39-44, 2021
39. 鈴木光幸．「質疑応答プロからプロへ」遺伝性膵炎の疫学，診断，治療法など最近の知見について.日本醫事新報55: 5096, 2021
40. 箕輪圭，鈴木光幸, 清水俊明．血液・腫瘍疾患治療中の症状とその対応 14.急性膵炎. 小児科診療85: 857-62, 2022
41. 鈴木光幸．ライソソーム病：疾患概念と在宅酵素補充療法．難病とケア28: 27-30, 2022
42. 齋藤暢知，鈴木光幸，清水俊明．小児急性膵炎の特徴. 消化器・肝臓内科12: 469-75, 2022
43. 中野聡，平井沙依子，鈴木光幸. 特集Ⅰ早期慢性膵炎，慢性膵炎をめぐる諸問題小児慢性膵炎の特徴と遺伝子異常. 消化器・肝臓内科12: 384-91, 2022
44. 岩原可名人, 西﨑直人, 織田敦子, 鈴木光幸, 草野弘宣, 谷川健, 鹿毛政義, 大日方薫, 岡﨑任晴, 清水俊明. 肝内胆管低形成による胆汁うっ滞型肝障害を認めた超低出生体重児の一例. 小児科臨床75: 365-70, 2022
45. 齊藤寛貴，金成彌，鈴木光幸，平井沙依子，長尾梓，山崎崇志，清水俊明．下肢矯正装具による内股歩行の治療中に異なる基礎疾患が判明した2例. 小児科臨床 75: 1-5, 2022

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

鈴木 光幸（スズキ ミツヨシ）

鈴木光幸（スズキミツヨシ）